Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.11
-0.56 (-4.10%)
Nov 18, 2024, 3:19 PM EST - Market open

Wave Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-142.52-57.51-161.82-122.25-149.91-193.64
Upgrade
Depreciation & Amortization
8.699.2110.119.849.989.2
Upgrade
Loss (Gain) From Sale of Assets
--0.01---
Upgrade
Stock-Based Compensation
12.259.817.1916.4114.319.51
Upgrade
Change in Accounts Receivable
7-21.09-302010
Upgrade
Change in Accounts Payable
0.15-3.769.35-6.575.12-3.5
Upgrade
Change in Unearned Revenue
-19.2354.33-3.25-18.46-20.08-15.98
Upgrade
Change in Other Net Operating Assets
-6.96-10.40.622.044.61-13.82
Upgrade
Operating Cash Flow
-140.62-19.43-127.78-88.99-115.98-188.23
Upgrade
Capital Expenditures
-1.21-1.12-1.36-0.56-1.34-3.92
Upgrade
Sale of Property, Plant & Equipment
--0.11---
Upgrade
Investing Cash Flow
-1.21-1.12-1.26-0.56-1.34-3.92
Upgrade
Issuance of Common Stock
298.77132.5352.9255.83154.54164.4
Upgrade
Other Financing Activities
14.1-14.27---
Upgrade
Financing Cash Flow
312.87132.5367.1955.83154.54164.4
Upgrade
Foreign Exchange Rate Adjustments
0.02-0.1-0.21-0.210.120.11
Upgrade
Net Cash Flow
171.07111.89-62.06-33.9337.34-27.64
Upgrade
Free Cash Flow
-141.83-20.55-129.14-89.55-117.32-192.15
Upgrade
Free Cash Flow Margin
-264.55%-18.13%-3539.11%-218.61%-584.35%-1202.21%
Upgrade
Free Cash Flow Per Share
-1.13-0.19-1.64-1.73-2.99-5.67
Upgrade
Levered Free Cash Flow
-0.3964.11-67.01-78.24-77.73-131.4
Upgrade
Unlevered Free Cash Flow
-0.3964.11-67.01-78.24-77.73-131.4
Upgrade
Change in Net Working Capital
-74.91-88.72-8.7524.544.8125.99
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.